Windtree reports positive Phase 2b study on heart failure therapy
WARRINGTON, Pa. - Windtree Therapeutics, Inc. (NASDAQ:WINT), a biotechnology firm specializing in the development of therapies for critical diseases and currently valued at $1.44 million market ...
AI in 2025: Five Defining Themes
Feature by Walter Sun, Sean Kask, Jonathan von Rueden NORTHAMPTON, MA / ACCESS Newswire / February 12, 2025 / Artificial intelligence (AI) is accelerating at an astonishing pace, quickly moving from e ...